Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

Laboratory Investigation

Volumn 88, Issue 2, 2008, Pages 153-160

  Jung, Yeonjoo ^a   Park, Jinah ^a   Bang, Yung Jue ^a   Kim, Tae You ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

DNMT inhibitor; Gastric cancer; NAP domain; Promoter hypermethylation; TSPYL5

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE INHIBITOR; GENOMIC DNA; TRICHOSTATIN A;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE; GENE SILENCING; GENE TARGETING; GLIOMA; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER; TSPYL5 GENE;

ADENOCARCINOMA; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS;

EID: 38549125699     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700706     Document Type: Article

References (36)

1. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;2(Suppl 1):S4-S11.
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
3. Rountree MR, Bachman KE, Herman JG, et al. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001;20:3156-3165.
4. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-993.
5. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-315.
6. Kang GH, Lee S, Kim JS, et al. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 2003;83:519-526.
7. Kim TY, Jong HS, Jung Y, et al. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004;20(Suppl 1):131-142.
8. Kusano M, Toyota M, Suzuki H, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 2006;106:1467-1479.
9. Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene 1999;18:7280-7286.
10. Song SH, Jong HS, Choi HH, et al. Methylation of specific CpG sites in the promoter region could significantly downregulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer 2000;87:236-240.
11. Song SH, Jong HS, Choi HH, et al. Transcriptional silencing of cyclooxygenase-2 by hyper-methylation of the 5′ CpG island in human gastric carcinoma cells. Cancer Res 2001;61:4628-4635.
12. Kim TY, Jong HS, Song SH, et al. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 2003;22:3943-3951.
13. Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004;84:479-484.
14. Choi MC, Jong HS, Kim TY, et al. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004;23:7095-7103.
15. Park J, Song SH, Kim TY, et al. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene 2004;23:3474-3480.
16. Kim TY, Zhong S, Fields CR, et al. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 2006;66:7490-7501.
17. Park YJ, Luger K. Structure and function of nucleosome assembly proteins. Biochem Cell Biol 2006;84:549-558.
18. Puffenberger EG, Hu-Lince D, Parod JM, et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci USA 2004;101:11689-11694.
19. Fujii-Nakata T, Ishimi Y, Okuda A, et al. Functional analysis of nucleosome assembly protein, NAP-1. The negatively charged COOH-terminal region is not necessary for the intrinsic assembly activity. J Biol Chem 1992;267:20980-20986.
20. Vogel T, Dittrich O, Mehraein Y, et al. Murine and human TSPYL genes: novel members of the TSPY-SET-NAP1L1 family. Cytogenet Cell Genet 1998;81:265-270.
21. Schnieders F, Dork T, Arnemann J, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 1996;5:1801-1807.
22. Ishimi Y, Kikuchi A. Identification and molecular cloning of yeast homolog of nucleosome assembly protein I which facilitates nucleosome assembly in vitro. J Biol Chem 1991;266:7025-7029.
23. Ishimi Y, Kojima M, Yamada M, et al. Binding mode of nucleosome-assembly protein (AP-I) and histones. Eur J Biochem 1987;162:19-24.
24. Park YJ, Chodaparambil JV, Bao Y, et al. Nucleosome assembly protein 1 exchanges histone H2A-H2B dimers and assists nucleosome sliding. J Biol Chem 2005;280:1817-1825.
25. Park YJ, Luger K. The structure of nucleosome assembly protein 1. Proc Natl Acad Sci USA 2006;103:1248-1253.
26. von Lindern M, van Baal S, Wiegant J, et al. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 1992;12:3346-3355.
27. Miyaji-Yamaguchi M, Kato K, Nakano R, et al. Involvement of nucleocytoplasmic shuttling of yeast Nap1 in mitotic progression. Mol Cell Biol 2003;23:6672-6684.
28. Oram SW, Liu XX, Lee TL, et al. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006;6:154.
29. Chai Z, Sarcevic B, Mawson A, et al. SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem 2001;276:33665-33674.
30. Wang GS, Hong CJ, Yen TY, et al. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 2004;42:113-128.
31. Ozbun LL, You L, Kiang S, et al. Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics 2001;73:179-193.
32. Gallagher WM, Bergin OE, Rafferty M, et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005;26:1856-1867.
33. Ku JL, Park JG. Biology of SNU cell lines. Cancer Res Treat 2005;37:1-19.
34. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
35. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-1431.
36. Momparler RL. Cancer epigenetics. Oncogene 2003;22:6479-6483.